Mechanism of H-8 inhibition of cyclin-dependent kinase 9: Study using inhibitor-immobilized matrices

Genes to Cells

Volumn 8, Issue 3, 2003, Pages 215-223

  Shima, Daisuke ^a   Yugami, Masato ^a   Tatsuno, Michiko ^a   Wada, Tadashi ^a   Yamaguchi, Yuki ^a   Handa, Hiroshi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ADENOSINE TRIPHOSPHATE; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; ELONGATION FACTOR; FLAVOPIRIDOL; LATEX; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; RNA POLYMERASE II;

ARTICLE; BINDING SITE; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CRYSTALLOGRAPHY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMOBILIZATION; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; OBSERVATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS; TRANSCRIPTION INITIATION;

ADENOSINE TRIPHOSPHATE; CYCLIN-DEPENDENT KINASE 9; CYCLIN-DEPENDENT KINASES; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; ENZYME INHIBITORS; HUMANS; ISOQUINOLINES; KINETICS; MICROSPHERES; SULFONAMIDES;

EID: 0037368027     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2443.2003.00627.x     Document Type: Article

References (46)

1. Bentley, D.L. (1995) Regulation of transcriptional elongation by RNA polymerase II. Curr. Opin. Genet. Dev. 5, 210-216.
2. Bieniasz, P.D., Grdina, T.A., Bogerd, H.P. & Cullen, B.R. (1998) Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17, 7056-7065.
3. Bieniasz, P.D., Grdina, T.A., Bogerd, H.P. & Cullen, B.R. (1999a) Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes. J. Virol. 73, 5777-5786.
4. Bieniasz, P.D., Grdina, T.A., Bogerd, H.P. & Cullen, B.R. (1999b) Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol. Cell. Biol. 19, 4592-4599.
5. Bossemeyer, E.J. (1995) Protein kinases - structure and function. FEBS Lett. 369, 57-61.
6. Carlson, B.A., Dubay, M.M., Sausville, E.A., Brizuela, L. & Worland, P.J. (1996) Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res. 56, 2973-2978.
7. Chao, S.H., Fujinaga, K., Marion, J.E., et al. (2000) Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J. Biol. Chem. 275, 28345-28348.
8. Chodosh, L.A., Fire, A., Samuels, M. & Sharp, P.A. (1989) 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264, 2250-2257.
9. Cox, S., Radzio-Andzelm, E. & Taylor, S.S. (1994) Domain movements in protein kinases. Curr. Opin. Struct. Biol. 4, 893-901.
10. De Azeved, W.F. Jr, Mueller-Dieckmann, H.J., Schulze-Gahmen, U., Worland, P.J., Sausville, E. & Kim, S.H. (1996) Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc. Natl. Acad. Sci. USA 93, 2735-2740.
11. Engh, R.A., Girod, A., Kinzel, V., Huber, R. & Bossemeyer, D. (1996) Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity. J. Biol. Chem. 271, 26157-26164.
12. Fraser, N.W., Sehgal, P.B. & Darnell, D.E. Jr (1979) Multiple discrete sites for premature RNA chain termination late in adenovirus-2 infection: enhancement by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Proc. Natl. Acad. Sci. USA 76, 2571-2575.
13. Goldsmith, E.J. & Cobb, M.H. (1994) Protein kinases. Curr. Opin. Struct. Biol. 4, 833-840.
14. Grana, X., De Luca, A., Sang, N., et al. (1994) PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. USA 91, 3834-3838.
15. Hidaka, H., Inagaki, M., Kawamoto, S. & Sasaki, Y. (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036-5041.
16. Hiramoto, M., Shimizu, N., Nishi, T., et al. (2002) High-performance affinity beads for identifying auti-NF-κB drug receptors. Meth. Enzymol. 353, 81-88.
17. 2+-activated, phospholipid-dependent and other protein kinases. J. Biol. Chem. 260, 2922-2925.
18. Inomata, Y., Kawaguchi, H., Hiramoto, M., Wada, T. & Handa, H. (1992) Direct purification of multiple ATF/E4TF3 polypeptides from HeLa cell crude nuclear extracts using DNA affinity latex particles. Anal. Biochem. 206, 109-114.
19. Johnsson, B., Lofas, S. & Lindqvist, G. (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198, 268-277.
20. Kawaguchi, H., Asai, A., Ohtsuka, Y., et al. (1989) Purification of DNA-binding transcription factors by their selective adsorption on the affinity latex particles. Nucl. Acids Res. 17, 6229-6240.
21. Kim, J.B. & Sharp, P.A. (2001) Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-ternimal domain independently of cyclin-dependent kinase-activating kinase. J. Biol. Chem. 276, 12317-12323.
22. Kjems, J., Calnan, B.J., Frankel, A.D. & Sharp, P.A. (1992) Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11, 1119-1129.
23. Knockaert, M., Gray, N., Damiens, E., et al. (2000) Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem. Biol. 7, 411-422.
24. Knockaert, M., Lenormand, P., Gray, N., Shultz, P., Pouyssegur, J. & Meijer, L. (2002) p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Oncogene 21, 6413-6424.
25. Losiewicz, M.D., Carlson, B.A., Kaur, G., Sausville, E.A. & Worland, P.J. (1994) Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun. 201, 589-295.
26. Mancebo, H.S., Lee, G., Flygare, J., et al. (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11, 2622-2632.
27. Marshall, N.F., Peng, J., Xie, Z. & Price, D.H. (1996) Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271, 27176-27183.
28. Marshall, N.F. & Price, D.H. (t992) Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12, 2078-2090.
29. Marshall, N.F. & Price, D.H. (1995) Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270, 12335-12338.
30. Morgan, D.O. & De Bondt, H.L. (1994) Protein kinase regulation: insights from crystal structure analysis. Curr. Opin. Cell Biol. 6, 239-246.
31. Peng, J., Zhu, Y., Milton, J.T. & Price, D.H. (1998) Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12, 755-762.
32. Price, D.H. (2000) P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20, 2629-2634.
33. Sehgal, P.B., Darnell, J.E. & Tamm, I. (1976) The inhibition by DRB (5,6-dichloro-1-β-D-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells. Cell 9, 473-480.
34. Senderowicz, A.M. & Sausville, E.A. (2000) RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators. J. Natl. Cancer Inst 92, 376-387.
35. Serizawa, H., Conaway, J.W. & Conaway, R.C. (1993) Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription. Nature 363, 371-374.
36. Shimizu, N., Sugimoto, K., Tang, J., et al. (2000) High-performance affinity beads for identifying drug receptors. Nature Biotechnol. 18, 877-881.
37. Tamm, I. & Kikuchi, T. (1979) Early termination of heterogeneous nuclear RNA transcripts in mammalian cells: accentuation by 5,6-dichloro 1-β-D-ribofuranosylbenzimidazole. Proc. Natl. Acad. Sci. USA 76, 5750-5754.
38. Taylor, S.S. & Radzio-Andzelm, E. (1994) Three protein kinase structures define a common motif. Structure 2, 345-355.
39. Thompson, C.M., Koleske, A.J., Chao, D.M. & Young, R.A. (1993) A multisubunit complex associated with the RNA polymerase II CTD and TATA-binding protein in yeast. Cell 73, 1361-1375.
40. Wada, T., Takagi, T., Yamaguchi, Y., et al. (1998a) DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12, 343-356.
41. Wada, T., Takagi, T., Yamaguchi, Y., Watanabe, D. & Handa, H. (1998b) Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17, 7395-7403.
42. Wada, T., Watanabe, H., Kawaguchi, H. & Handa, H. (1995) DNA affinity chromatography. Meth. Enzymol. 254, 595-604.
43. Wei, P., Garber, M.E., Fang, S.M., Fisher, W.H. & Jones, K.A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92, 451-462.
44. Yamaguchi, Y., Takagi, T., Wada, T., et al. (1999a) NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97, 41-51.
45. Yamaguchi, Y., Wada, T., Watanabe, D., Takagi, T., Hasegawa, J. & Handa, H. (1999b) Structure and function of the human transcription elongation factor DSIF. J. Biol. Chem. 274, 8085-8809.
46. Zhu, Y., Pe'ery, T., Peng, J., et al. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11, 2622-2632.